0 NASDAQ Companies - February 1, 2024Immuneering Announces Participation in February Investor ConferencesCAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF […]Read More
0 NYSE Companies - February 1, 2024Gran Tierra Energy Inc. Announces Private Offering of an Additional Amount of its 9.500% Senior Secured Amortizing Notes due 2029CALGARY, Alberta, Feb. 01, 2024 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) today […]Read More
0 TSX Venture News - February 1, 2024Earth Alive Acquires Interlube and Completes Simplified Vertical MergerMONTREAL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC – “Earth Alive” or the “Company”), […]Read More
0 NASDAQ Companies - February 1, 2024The Shyft Group Announces Quarterly DividendNOVI, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North […]Read More
0 NYSE Companies - February 1, 2024Parker Reports Fiscal 2024 Second Quarter ResultsSales increased 3% to $4.8 billion; organic sales increased 3% Segment operating margin was 21.1%, or a record 24.5% adjusted, […]Read More
0 NASDAQ Companies - February 1, 2024Dyne Therapeutics to Present at February Investor ConferencesWALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]Read More
0 NASDAQ Companies - February 1, 2024Kelly Announces Fourth-Quarter Conference CallTROY, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — Kelly, a leading global specialty talent solutions provider, will release its fourth-quarter […]Read More
0 NASDAQ Companies - February 1, 2024Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024CINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based […]Read More
0 NASDAQ Companies - February 1, 2024Purple Biotech Reaches Recommended Phase 2 Dose for NT219REHOVOT, Israel, Feb. 01, 2024 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage […]Read More
0 NASDAQ Companies - February 1, 2024Hillman Sets Fourth Quarter 2023 Earnings Release and Results Presentation DateCINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and […]Read More